Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Cáncer (11)

2024

  1. Detection of minimal residual disease in acute myeloid leukemia: evaluating utility and challenges

    Frontiers in Immunology, Vol. 15

  2. Real-World Impact of Deep Targeted Sequencing on Erythrocytosis and Thrombocytosis Diagnosis: A Reference Centre Experience

    Cancers, Vol. 16, Núm. 18

2023

  1. Posttranslational splicing modifications as a key mechanism in cytarabine resistance in acute myeloid leukemia

    Leukemia, Vol. 37, Núm. 8, pp. 1649-1659

2022

  1. Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA

    Scientific Reports, Vol. 12, Núm. 1

  2. NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial

    Cancers, Vol. 14, Núm. 20

  3. The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients

    Frontiers in Oncology, Vol. 12

2020

  1. A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics

    Blood Cancer Journal, Vol. 10, Núm. 4

  2. Analysis of SNP Array Abnormalities in Patients with DE NOVO Acute Myeloid Leukemia with Normal Karyotype

    Scientific Reports, Vol. 10, Núm. 1

  3. Novel DNMT3A germline variant in a patient with multiple paragangliomas and papillary thyroid carcinoma

    Cancers, Vol. 12, Núm. 11, pp. 1-12

2019

  1. A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia

    Haematologica, Vol. 104, Núm. 2, pp. 288-296

  2. Minimal residual disease monitoring with next- generation sequencing methodologies in hematological malignancies

    International Journal of Molecular Sciences, Vol. 20, Núm. 11